Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera
Author:
Funder
CSL Behring France
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology
Link
https://link.springer.com/content/pdf/10.1007/s00415-020-10041-z.pdf
Reference33 articles.
1. Joint Task Force of the EFNS and the PNS (2010) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripher. J Peripher Nerv Syst 15:185–195
2. Querol L, Nogales-Gadea G, Rojas-Garcia R et al (2013) Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 73:370–380
3. Ng JKM, Malotka J, Kawakami N et al (2012) Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 79:2241–2248
4. Doppler K, Appeltshauser L, Villmann C et al (2016) Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy. Brain 139:2617–2630. https://doi.org/10.1093/brain/aww189
5. Delmont E, Manso C, Querol L et al (2017) Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy. Brain 140:1851–1858. https://doi.org/10.1093/brain/awx124
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Upper and lower limb tremor in inflammatory neuropathies;Clinical Neurophysiology;2024-02
2. Clinical efficacy of anti-CD20 antibodies in neurological and neuromuscular diseases;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024
3. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort;Journal of Neurology, Neurosurgery & Psychiatry;2023-10-25
4. Pan-Neurofascin autoimmune nodopathy – a life-threatening, but reversible neuropathy;Current Opinion in Neurology;2023-07-28
5. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease;Frontiers in Immunology;2023-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3